期刊文献+

抗癫痫药物诱导儿童过敏反应病例分析 被引量:3

原文传递
导出
摘要 目的:分析抗癫痫药物临床使用时诱导儿童过敏反应发生的特点和规律。方法:报告7例抗癫痫药物诱导儿童过敏反应及参考国内文献。结果:芳香族与非芳香族抗癫痫药物均可引起过敏反应,以芳香族抗癫痫药物为主,大多发生在服药后的两周之内,严重时可发生高敏综合征,糖皮质激素是其治疗的首选药物之一。结论:抗癫痫药物可以诱导儿童过敏反应,在儿科应用时应严格掌握药物说明书,并交代家长注意观察不良反应,保障儿童用药安全。
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2013年第2期159-160,共2页 Chinese Journal of Hospital Pharmacy
基金 江苏省南京市医学重点科技发展项目资助(编号:ZKX10024)
  • 相关文献

参考文献14

二级参考文献50

  • 1高蓉 钱连华.卡马西平的少见毒副作用[J].临床脑电学杂志,1994,3(4):246-248.
  • 2Griffin JW,Li CY,Ho n Ⅳ,et al,Guillain-Barre' syndrome innorthern China:the spectrum of neuropathological changes inclinically defined cases.Brain,1995,118:577-595.
  • 3Roujeau JC.The spectrum of Stevens-Johnson syndrome and toxic epidermal necrolysis:a clinical classification.J Invest Dermatol,1994,102:28S-30S.
  • 4Schlienger RG,Shear NH.Antiepileptic drug hypersensitivity syndrome.Epilepsia,1998,39 Suppl 7:S3-S7.
  • 5Nasisbitt DJ,Britschgi M,Wong G,et al.Hypersensitivity reactionsto carbamazepine:characterization of the specificity,phenotypeand cytokine profile of drug-specific T cell clones.Mol Pharmaeoi,2003,63:732-741.
  • 6Nassif A,Beusnssan A,Boumsell L,et al.Toxic epidermalnecrolysis:effector cells ale drug-specific cytotoxic Tceils.J Allergy Clin Lmmunol,2004,114:1209-1215.
  • 7Hung SI,Chung WH,Jee SH,et al.Gentic susceptibility tocarbamazepine.induced cutaneous adverse drug reactions.Pharmacogenet Genomics,2006,16:297-306.
  • 8Man CB,Kwan P,Baum L,et al.Association between HLA-B *1502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese.Epilepsia,2007,48:1015-1018.
  • 9Alfirevic A,Jorgensen AL,Williamson PR,et al.HLA-B locus in Caucasian patients with carbamazepine hypersensitivity.Pharmacogenomics,2006,7:813-818.
  • 10Lonjou C,Thomas L,Borot N,et al.A marker for StevensJohnson syndrome ethnicity matters.Pharmacogenomics J,2006,6:265-268.

共引文献56

同被引文献28

  • 1孙艳,朱曼,郭代红,张莉.苯巴比妥不良反应12年间的国内文献源分析[J].中国新药杂志,2006,15(15):1302-1304. 被引量:10
  • 2PERUCCA E. Pharmacokinetic profile of topiramate in compar- ison with other new antiepileptic drugs [ J]. Epilepsia, 1996,37 (2) :8-10.
  • 3GLAUSER T A, DLUGOS D J, DODSON W E, et al. Topira- mate monotherapy in newly diagnosed epilepsy in children and adolescents [ J 1. J Child Neurol, 2007,22 ( 6 ) : 693- 699.
  • 4WEINTRAUB D, BUCHSBAUM R, RESOR SR J R, et al. Psychiatric and behavioral side effects of newer antiepileptic drugs in adults with epilepsy [ J ]. Epilepsia Behav, 2007,10 (1) :105-110.
  • 5POTSCHKA H, LUNA M H. CNS transporters and drug delivery in epilepsy [J]. Curr Pharm Des, 2014, 20(10): 1534-1542.
  • 6MA A, WANG C, CHEN Y, et al. P-glycoprotein alters blood-brain barrier penetration of antiepileptic drugs in rats with medically intractable epilepsy [J]. Drug Des Devel Ther, 2013(7): 1447-1454.
  • 7IWANAGA K, YONEDA S, HAMAHATA Y, et al. Inhibitory effects of furanocoumarin derivatives in kampo extract medicines on P-glycoprotein at the blood-brain barrier [J]. Biol Pharm Bull, 2011, 34(8): 1246-1251.
  • 8中国药理学会药物代谢专业委员会.第9届全国药物和化学异物代谢学术会议论文集,武汉,October 23-26,2009[C].北京:中国知网,c2009.
  • 9RACINE R J. Modification of seizure activity by electrical stimulation. II. Motor seizure [J]. Electroencephalogr Clin Neurophysiol, 1972, 32(3): 281-294.
  • 10BOLWING T G. Brain-Blood Barrier studied with special reference to epileptic seizures [J]. Acta Psychiatr Scand Suppl, 1983(345): 15-20.

引证文献3

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部